Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study

被引:78
作者
Jacques, PF
Bostom, AG
Selhub, J
Rich, S
Ellison, RC
Eckfeldt, JH
Gravel, RA
Rozen, R
机构
[1] Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer USDA, Boston, MA 02111 USA
[2] Mem Hosp Rhode Isl, Div Gen Internal Med, Providence, RI USA
[3] NHLBI, Family Heart Study Field Ctr, Framingham, MA USA
[4] Boston Univ, Sch Med, Boston, MA 02118 USA
[5] Univ Minnesota, Dept Lab Med & Pathol, NHLBI, Family Heart Study Cent Lab, Minneapolis, MN 55455 USA
[6] Univ Calgary, Dept Kinesiol, Calgary, AB, Canada
[7] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB, Canada
[8] McGill Univ, Montreal Childrens Hosp, Dept Human Genet, Montreal, PQ H3H 1P3, Canada
[9] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada
[10] McGill Univ, Montreal Childrens Hosp, Dept Biol, Montreal, PQ H3H 1P3, Canada
关键词
homocysteine; methionine synthase; methionine synthase reductase; B vitamins; epidemiologic study;
D O I
10.1016/S0021-9150(02)00204-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The metabolism of homocysteine requires contributions of several enzymes and vitamin cofactors. Earlier studies identified a common polymorphism of methylenetetrahydrofolate reductase that was associated with mild hyperhomocysteinemia. Common variants of two other enzymes involved in homocysteine metabolism, methionine synthase and methionine synthase reductase, have also been identified. Methionine synthase catalyzes the remethylation of homocysteine to form methionine and methionine synthase reductase is required for the reductive activation of the cobalamin-dependent methionine synthase. The methionine synthase gene (MTR) mutation is an A to G substitution, 2756A --> G, which converts an aspartate to a glycine codon. The methionine synthase reductase gene (MTRR) mutation is an A to G substitution, 66A --> G, that converts an isoleucine to a methionine residue. To determine if these polymorphisms were associated with mild hyperhomocysteinemia, we investigated subjects from two of the NHLBI Family Heart Study field centers, Framingham and Utah. Total plasma homocysteine concentrations were determined after an overnight fast and after a 4-h methionine load test. MTR and MTRR genotype data were available for 677 and 562 subjects, respectively. The geometric mean fasting homocysteine was unrelated to the MTR or MTRR genotype categories (AA, AG, GG). After a methionine load, a weak positive association was observed between change in homocysteine after a methionine load and the number of mutant MTR alleles (P-trend = 0.04), but this association was not statistically significant according to the overall F-statistic (P = 0.12). There was no significant interaction between MTR and MTRR genotype or between these genotypes and any of the vitamins with respect to homocysteine concentrations. This study provides no evidence that these common MTR and MTRR mutations are associated with alterations in plasma homocysteine. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 30 条
[1]   DETERMINATION OF FREE AND TOTAL HOMOCYSTEINE IN HUMAN-PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
ARAKI, A ;
SAKO, Y .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 422 :43-52
[2]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[3]  
BRATTSTROM L, 1989, HAEMOSTASIS, V19, P35
[4]  
Brown CA, 2000, J CARDIOVASC RISK, V7, P197
[5]   Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction [J].
Chen, J ;
Stampfer, MJ ;
Ma, J ;
Selhub, J ;
Malinow, MR ;
Hennekens, CH ;
Hunter, DJ .
ATHEROSCLEROSIS, 2001, 154 (03) :667-672
[6]   Human methionine synthase - cDNA cloning, gene localization and expression [J].
Chen, LH ;
Liu, ML ;
Hwang, HY ;
Chen, LS ;
Korenberg, J ;
Shane, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) :3628-3634
[7]  
D'Angelo A, 2000, THROMB HAEMOSTASIS, V83, P563
[8]   Gene-environment and gene-gene interaction in the determination at plasma homocysteine levels in healthy middle-aged men [J].
Dekou, V ;
Gudnason, V ;
Hawe, E ;
Miller, GJ ;
Stansbie, D ;
Humphries, SE .
THROMBOSIS AND HAEMOSTASIS, 2001, 85 (01) :67-74
[9]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[10]   Plasma homocysteine as a risk factor for vascular disease - The European concerted action project [J].
Graham, IM ;
Daly, LE ;
Refsum, HM ;
Robinson, K ;
Brattstrom, LE ;
Ueland, PM ;
PalmaReis, RJ ;
Boers, GHJ ;
Sheahan, RG ;
Israelsson, B ;
Uiterwaal, CS ;
Meleady, R ;
McMaster, D ;
Verhoef, P ;
Witteman, J ;
Rubba, P ;
Bellet, H ;
Wautrecht, JC ;
deValk, HW ;
Luis, ACS ;
ParrotRoulaud, FM ;
Tan, KS ;
Higgins, I ;
Garcon, D ;
Medrano, MJ ;
Candito, M ;
Evans, AE ;
Andria, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22) :1775-1781